Florian Scherer

Alıntı yapanlar

	Hepsi	2019 yılından bugüne
Alıntılar	7868	6997
h-endeksi	24	23
i10-endeksi	36	32

2000

1000

500

1500

201620172018201920202021202220232024106 279 445 545 825 1314 1588 1907 800

Genel erişim

Tümünü görüntüle

32 makale

1 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Ash A. Alizadeh, MD, PhDStanford University, Moghadam Family Professor of Medicinestanford.edu üzerinde doğrulanmış e-posta adresine sahip
Maximilian DiehnStanford Universitystanford.edu üzerinde doğrulanmış e-posta adresine sahip
David M. KurtzAssistant Professor of Medicine, Stanford Universitystanford.edu üzerinde doğrulanmış e-posta adresine sahip
Mohammad Shahrokh EsfahaniAssistant Professor of Radiation Oncology, Stanford Universitystanford.edu üzerinde doğrulanmış e-posta adresine sahip
Aaron M NewmanAssistant Professor of Biomedical Data Science, Stanford Universitystanford.edu üzerinde doğrulanmış e-posta adresine sahip
Jake ChabonCEO/CSO, Foresight Diagnostics Inc.stanford.edu üzerinde doğrulanmış e-posta adresine sahip
Daniel M. KlassDirector of Research and Early Development for NGS Assays, Roche Diagnosticsfreenome.com üzerinde doğrulanmış e-posta adresine sahip
Joanne SooDuke University School of Medicineduke.edu üzerinde doğrulanmış e-posta adresine sahip
Davide RossiOncology Institute of Southern Switzerlandeoc.ch üzerinde doğrulanmış e-posta adresine sahip
Scott V Bratman, MD PhDSenior Scientist (Principal Investigator), Princess Margaret Cancer Centre, University Healthuhnresearch.ca üzerinde doğrulanmış e-posta adresine sahip
Duque-AfonsoHematologist/Oncologist, University Medical Center Freiburguniklinik-freiburg.de üzerinde doğrulanmış e-posta adresine sahip
Michael R. GreenMD Anderson Cancer Centermdanderson.org üzerinde doğrulanmış e-posta adresine sahip
Robert TibshiraniProfessor of Biomedical Data Sciences, and of Statistics, Stanford Universitystanford.edu üzerinde doğrulanmış e-posta adresine sahip
Marcelo NavarreteProfessor of Molecular Medicine, University of Magallanesumag.cl üzerinde doğrulanmış e-posta adresine sahip
Eric T. KoolStanford Universitystanford.edu üzerinde doğrulanmış e-posta adresine sahip
Saswata Karmakar, Ph.DStanford Universitystanford.edu üzerinde doğrulanmış e-posta adresine sahip
Szymon M. KiełbasaBiomedical Data Scienceslumc.nl üzerinde doğrulanmış e-posta adresine sahip
Sanjiv S. GambhirProfessor of Radiology, Stanford Universitystanford.edu üzerinde doğrulanmış e-posta adresine sahip
Max JanMassachusetts General Hospitalpartners.org üzerinde doğrulanmış e-posta adresine sahip

Takip et

Florian Scherer

Clinician Scientist and PI, Hematology and Oncology, University Medical Center Freiburg

uniklinik-freiburg.de üzerinde doğrulanmış e-posta adresine sahip

Lymphoma Circulating tumor DNA Liquid Biopsy Cancer systems biology Biomarker development


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Determining cell type abundance and expression from bulk tissues with digital cytometry AM Newman, CB Steen, CL Liu, AJ Gentles, AA Chaudhuri, F Scherer, ... Nature biotechnology 37 (7), 773-782, 2019	2633	2019
Integrated digital error suppression for improved detection of circulating tumor DNA AM Newman, AF Lovejoy, DM Klass* (Co-First), DM Kurtz, JJ Chabon, ... Nature biotechnology 34 (5), 547-555, 2016	1055	2016
Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling AA Chaudhuri, JJ Chabon, AF Lovejoy, AM Newman, H Stehr, TD Azad, ... Cancer discovery 7 (12), 1394-1403, 2017	785	2017
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients JJ Chabon, AD Simmons (Co-First), AF Lovejoy, MS Esfahani, ... Nature communications 7 (1), 1-15, 2016	630	2016
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA F Scherer, DM Kurtz, AM Newman* (Co-First), H Stehr, AFM Craig, ... Science translational medicine 8 (364), 364ra155-364ra155, 2016	432	2016
Circulating tumor DNA measurements as early outcome predictors in diffuse large B-cell lymphoma DM Kurtz, F Scherer (Co-First), MC Jin, J Soo, AFM Craig, MS Esfahani, ... Journal of Clinical Oncology 36 (28), 2845, 2018	387	2018
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing DM Kurtz, MR Green (Co-First), SV Bratman, F Scherer, CL Liu, ... Blood, The Journal of the American Society of Hematology 125 (24), 3679-3687, 2015	343	2015
Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma VM Ravi, P Will, J Kueckelhaus, N Sun, K Joseph, H Salié, L Vollmer, ... Cancer cell 40 (6), 639-655. e13, 2022	191	2022
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA DM Kurtz, J Soo, L Co Ting Keh, S Alig, JJ Chabon, BJ Sworder, A Schultz, ... Nature biotechnology 39 (12), 1537-1547, 2021	180	2021
Dynamic risk profiling using serial tumor biomarkers for personalized outcome prediction DM Kurtz, MS Esfahani, F Scherer* (Co-First), J Soo, MC Jin, CL Liu, ... Cell 178 (3), 699-713. e19, 2019	166	2019
T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10 VM Ravi, N Neidert, P Will, K Joseph, JP Maier, J Kückelhaus, L Vollmer, ... Nature communications 13 (1), 925, 2022	127	2022
Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer Discov. 2017; 7: 1394–1403. doi: 10.1158/2159-8290 AA Chaudhuri, JJ Chabon, AF Lovejoy, AM Newman, H Stehr, TD Azad, ... CD-17-0716.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0	94
High-throughput sequencing for noninvasive disease detection in hematologic malignancies F Scherer, DM Kurtz (Co-First), M Diehn, AA Alizadeh Blood 130 (4), 440-452, 2017	81	2017
Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia J Duque-Afonso, J Feng, F Scherer, CH Lin, SHK Wong, Z Wang, ... The Journal of Clinical Investigation 125 (9), 3667-3680, 2015	73	2015
Organocatalytic removal of formaldehyde adducts from RNA and DNA bases S Karmakar, EM Harcourt, DS Hewings, F Scherer, AF Lovejoy, DM Kurtz, ... Nature chemistry 7 (9), 752-758, 2015	57	2015
Early assessment of circulating tumor DNA after curative‐intent resection predicts tumor recurrence in early‐stage and locally advanced non‐small‐cell lung cancer S Waldeck, J Mitschke, S Wiesemann, M Rassner, G Andrieux, M Deuter, ... Molecular oncology 16 (2), 527-537, 2022	52	2022
Short diagnosis-to-treatment interval is associated with higher circulating tumor DNA levels in diffuse large B-cell lymphoma S Alig, CW Macaulay, DM Kurtz, U Dührsen, A Hüttmann, C Schmitz, ... Journal of Clinical Oncology 39 (23), 2605-2616, 2021	43	2021
Circulating tumor DNA profiling for detection, risk stratification, and classification of brain lymphomas JA Mutter, SK Alig, MS Esfahani, EM Lauer, J Mitschke, DM Kurtz, J Kühn, ... Journal of Clinical Oncology 41 (9), 1684-1694, 2023	39	2023
High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot study E Schorb, B Kasenda, G Ihorst, F Scherer, J Wendler, L Isbell, H Fricker, ... Blood advances 4 (14), 3378-3381, 2020	38	2020
Transitioning the molecular tumor board from proof of concept to clinical routine: a German single-center analysis R Hoefflin, A Lazarou, ME Hess, M Reiser, J Wehrle, P Metzger, AV Frey, ... Cancers 13 (5), 1151, 2021	35	2021

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar